Announcements Trials
Browse Landscape

Status

Completed 38Terminated 30Recruiting 20Unknown 9Not yet recruiting 5Active not recruiting 4Withdrawn 3Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 3Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 4Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Melanoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Recurrence 1Osteosarcoma 1Neurofibrosarcoma 1Neuroblastoma 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Chordoma 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma 1Breast Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Recurrence × Thoracic × Clear all
NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Second Life Therapeutics

Available
CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡